Mollie S. Schubert
Integrated DNA Technologies (United States)(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, CAR-T cell therapy research, Immune Cell Function and Interaction, Advanced biosensing and bioanalysis techniques, T-cell and B-cell Immunology
Most-Cited Works
- → CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy(2020)554 cited
- → Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells(2020)275 cited
- → AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines(2021)167 cited
- → Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair(2021)113 cited
- → Comparison of CRISPR-Cas9/Cas12a Ribonucleoprotein Complexes for Genome Editing Efficiency in the Rice Phytoene Desaturase (OsPDS) Gene(2020)106 cited
- → Chemical Modification of CRISPR gRNAs Eliminate type I Interferon Responses in Human Peripheral Blood Mononuclear Cells(2018)34 cited
- → Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells(2020)33 cited
- → Efficiency, Specificity and Temperature Sensitivity of Cas9 and Cas12a RNPs for DNA-free Genome Editing in Plants(2022)29 cited
- → Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency(2021)24 cited
- → Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines(2021)10 cited